Docket Room.
S 2035·MA·senate

An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing

FailedFiled Feb 27, 2025
Sponsor: Jason M. Lewis (D)
Latest Action

Accompanied a study order, see H5596

Jul 23, 2026

Email me when S 2035 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track S 2035. By continuing you agree to the Terms and Privacy Policy.

Summary

The Senate bill seeks to remove the state tax deduction that pharmaceutical firms currently claim for advertising directly to consumers. It would affect drug manufacturers and could increase state tax revenue while reducing incentives for aggressive consumer‑focused marketing.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about S 2035

3 free questions a day, no account

Hearings

History

  1. Reporting date extended to Thursday June 25, 2026
  2. Hearing scheduled for 10/28/2025 from 01:00 PM-05:00 PM in B-2
  3. Referred to the committee on Revenue
  4. House concurred

Sponsors

  • Jason M. Lewis (D) · sponsor
  • Rebecca L. Rausch

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when S 2035 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track S 2035 free

Or ask your AI assistant about S 2035 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice